OPSM has started delivering audiology services in Australia and New Zealand, and its Nuance Audio Glasses for people with mild to...
Read moreDetailsThe Therapeutic Goods Administration (TGA) has approved Neuromod Devices’ Lenire tongue stimulation device for use by tinnitus patients in Australia,...
Read moreDetailsAustralians with post-transplant cytomegalovirus, which can cause hearing loss, now have access to a new medicine under the Pharmaceutical Benefits...
Read moreDetailsApple’s AirPods Pro 2 can now be used as hearing aids in Australia for adults with mild to moderate hearing...
Read moreDetailsAustralia’s Therapeutic Goods Administration (TGA) is evaluating Norgine Pharmaceutical’s PEDMARQSI for the prevention of hearing loss induced by cisplatin chemotherapy...
Read moreDetailsAmerica’s Food and Drug Administration (FDA) has approved Gomekli as the first drug to treat neurofibromatosis type 1 (NF1) in...
Read moreDetailsEyewear company Essilor Luxottica has announced that its ‘hearing glasses’ – spectacles that include hearing aids – have received approval...
Read moreDetailsAustralia’s health ministers have agreed to add x-linked adrenoleukodystrophy (X-ALD) to Australia's screening programs for male newborns and commissioned further...
Read moreDetailsThe UK Government has given the green light for over-the-counter (OTC) hearing aids and devices to be sold in the...
Read moreDetailsAmerican doctors have documented 84 hearing-related adverse events in patients taking teprotumumab (Tepezza) for thyroid eye disease, a treatment which...
Read moreDetails
Hearing Practitioner Australia is the only independent business-to-business publication for the nation’s hearing industry. The multi-channel platform has been established out of the need for premium, local and independent content relevant to today’s audiologists, audiometrists, otolaryngologists/ENTs and other hearing professionals in Australia.
© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited